205 related articles for article (PubMed ID: 18789853)
1. Incorrect identification of Streptococcus pneumoniae and its effect on antimicrobial resistance rates.
Song JH; Baek JY; Cheong HS; Peck KR; Ko KS
Int J Antimicrob Agents; 2009 Jan; 33(1):93-5. PubMed ID: 18789853
[No Abstract] [Full Text] [Related]
2. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of a capsular and antibiotype variant of the England-9 pneumococcal clone in the Czech Republic.
Zemlicková H; Jakubů V; Urbásková P
Clin Microbiol Infect; 2007 Jun; 13(6):648-51. PubMed ID: 17371538
[TBL] [Abstract][Full Text] [Related]
4. Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone.
Ardanuy C; Fenoll A; Berrón S; Calatayud L; Liñares J
Antimicrob Agents Chemother; 2006 Sep; 50(9):3162-5. PubMed ID: 16940119
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
6. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated in Tunisia.
Rachdi M; Boutiba-Ben Boubaker I; Mahjoubi-Rhimi F; Smaoui H; Hammami A; Kéchrid A; Slim A; Ben Redjeb S
J Med Microbiol; 2011 Mar; 60(Pt 3):391-393. PubMed ID: 21071543
[No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility of Streptococcus pneumoniae in the oropharynx of healthy preschool children and identification of risk factors.
Oguzkaya Artan M; Baykan Z; Artan C
Jpn J Infect Dis; 2008 Jul; 61(4):302-3. PubMed ID: 18653974
[TBL] [Abstract][Full Text] [Related]
8. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia.
Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W
J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511
[No Abstract] [Full Text] [Related]
10. Streptococcus pneumoniae diseases in Chinese children: past, present and future.
Yao KH; Yang YH
Vaccine; 2008 Aug; 26(35):4425-33. PubMed ID: 18602435
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal resistance in the postvaccine era.
Temime L; Guillemot D; Boëlle PY
Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
[No Abstract] [Full Text] [Related]
12. The antimicrobial resistance profile of Streptococcus pneumoniae.
Reinert RR
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
Le Hello S; Page S; Garin B
Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
[No Abstract] [Full Text] [Related]
14. Significance of macrolide resistance in Streptococcus pneumoniae.
Nuermberger EL; Bishai WR
J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
[No Abstract] [Full Text] [Related]
15. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
16. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
17. Survey of antimicrobial susceptibility of community isolates of Streptococcus pneumoniae in Ontario.
Mazzulli T; Simor AE; Jaeger R; Fuller S; Low DE
Can Dis Wkly Rep; 1989 Jul; 15(26):131-3. PubMed ID: 2758485
[No Abstract] [Full Text] [Related]
18. Increased resistance of Streptococcus pneumoniae isolates to antimicrobial drugs, at a referral hospital in north-west Ethiopia.
Erqou S; Kebede Y; Mulu A
Trop Doct; 2008 Apr; 38(2):110-2. PubMed ID: 18453508
[TBL] [Abstract][Full Text] [Related]
19. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae: presumptive identification and reporting.
Rich M; Memish ZA
Br J Biomed Sci; 2002; 59(1):65. PubMed ID: 12000190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
